SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that a peer-reviewed ...
Discover how targeted treatment improved survival in cholangiocarcinoma and why access gaps remain. Learn more.
Differences in genomic profiles, targeted treatment use, and overall survival in patients with metastatic breast cancer by Area Deprivation Index. This is an ASCO Meeting Abstract from the 2025 ASCO ...
NanoString’s Digital Spatial Profiling Platform Used to Create Foundational Dataset Revealing Insights into COVID-19 RNAScope (left) was utilized to assess the SARS-CoV-2 viral load of autopsy samples ...